Related Articles
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
Cardiotoxicity associated with targeted cancer therapies (Review)
BIIB021, an Hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review)
Emerging targeted therapies for melanoma treatment (Review)
Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review)